ES2065951T3 - Uso de un inhibidor de prolilendopeptidasa para el tratamiento del sida. - Google Patents

Uso de un inhibidor de prolilendopeptidasa para el tratamiento del sida.

Info

Publication number
ES2065951T3
ES2065951T3 ES89113351T ES89113351T ES2065951T3 ES 2065951 T3 ES2065951 T3 ES 2065951T3 ES 89113351 T ES89113351 T ES 89113351T ES 89113351 T ES89113351 T ES 89113351T ES 2065951 T3 ES2065951 T3 ES 2065951T3
Authority
ES
Spain
Prior art keywords
aids
treatment
inhibitor
prolylendopeptidase
prolylendopeptidase inhibitor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES89113351T
Other languages
English (en)
Inventor
Kiyoshi Takatsuki
Toshio Hattori
Daisuke Tsuru
Tadashi Yoshimoto
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yakult Honsha Co Ltd
Original Assignee
Yakult Honsha Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yakult Honsha Co Ltd filed Critical Yakult Honsha Co Ltd
Application granted granted Critical
Publication of ES2065951T3 publication Critical patent/ES2065951T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/005—Enzyme inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pyrrole Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

SE DESCRIBEN AGENTES PREVENTIVOS Y CURATIVOS PARA EL SINDROME DE INMUNO DEFICIENCIA ADQUIRIDA Y AGENTES ANTI-HIV. CONTIENEN UN INHIBIDOR PROLILENDOPEPTIDASA COMO UN INGREDIENTE EFECTIVO.
ES89113351T 1988-07-25 1989-07-20 Uso de un inhibidor de prolilendopeptidasa para el tratamiento del sida. Expired - Lifetime ES2065951T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP18525988 1988-07-25

Publications (1)

Publication Number Publication Date
ES2065951T3 true ES2065951T3 (es) 1995-03-01

Family

ID=16167692

Family Applications (1)

Application Number Title Priority Date Filing Date
ES89113351T Expired - Lifetime ES2065951T3 (es) 1988-07-25 1989-07-20 Uso de un inhibidor de prolilendopeptidasa para el tratamiento del sida.

Country Status (7)

Country Link
EP (1) EP0355409B1 (es)
JP (1) JPH02124818A (es)
KR (1) KR0124028B1 (es)
AT (1) ATE113843T1 (es)
CA (1) CA1335079C (es)
DE (1) DE68919301T2 (es)
ES (1) ES2065951T3 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5449750A (en) * 1991-06-20 1995-09-12 Snow Brand Milk Products Co., Ltd. Prolyl endopeptidase inhibitors SNA-115 and SNA-115T, and process for the production and productive strain thereof
HUP9700442A1 (hu) * 1997-02-14 1999-09-28 Chinoin Gyógyszer és Vegyészeti Termékek Gyára Rt. Gyűrűs amidszármazékok, e vegyületeket tartalmazó gyógyászati készítmények, eljárás előállításukra és alkalmazásuk
CN115778946B (zh) * 2022-11-04 2023-08-01 中国农业科学院兰州兽医研究所 化合物zpp在制备抗病毒药物中的应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60188317A (ja) * 1984-03-09 1985-09-25 Yakult Honsha Co Ltd 抗健忘症剤

Also Published As

Publication number Publication date
EP0355409A3 (en) 1991-04-03
DE68919301T2 (de) 1995-06-08
EP0355409A2 (en) 1990-02-28
ATE113843T1 (de) 1994-11-15
KR0124028B1 (ko) 1997-11-27
JPH02124818A (ja) 1990-05-14
DE68919301D1 (de) 1994-12-15
EP0355409B1 (en) 1994-11-09
CA1335079C (en) 1995-04-04
KR900001368A (ko) 1990-02-27

Similar Documents

Publication Publication Date Title
FI893962A7 (fi) HIV-proteaasi-inhibiittoreita, jotka ovat hyödyllisiä AIDS:in hoidossa
FI906212A7 (fi) HIV-proteaasin inhibiittoreita, jotka ovat käyttökelpoisia AIDSin hoidossa
ES2071484T3 (es) Derivados de 2,4-diaminoquinazolinas para aumentar la actividad antitumoral.
FI942112L (fi) AIDS:n hoidossa käyttökelpoisia HIV-proteaasi-inhibiittoreita
HU9301447D0 (en) Inhibitors of retrovirus protease
ATE185483T1 (de) Antivirale nucleosidkombination
RU95106823A (ru) Сукциноиламиногидроксиэтиламиносульфонамиды, фармацевтическая композиция, способ ингибирования ретровирусной протеазы, способ лечения ретровирусной инфекции способ лечения спида
ES2156107T3 (es) Un fgf-4 no glicosilado y composiciones que lo contienen.
ES2083597T3 (es) Preparacion farmaceutica para el tratamiento del tiempo de coagulacion prolongado.
FI923158A7 (fi) HIV-proteaasin inhibiittoreita, jotka ovat hyödyllisiä AIDSin hoidossa
ES2063202T3 (es) Nuevas 5,11-dihidro-6h-dipirido(3,2-b:2',3'-e)(1,4)diazepin-6-onas y -tionas y su uso en la prevencion o tratamiento del sida.
ATE78696T1 (de) Arzneimittelzubereitung zur behandlung des immunmangels.
ID24184A (id) Obat untuk perawatan disfungsi ereksi
OA09917A (en) Compounds for use in treating HIV infection
ATE81004T1 (de) Laktamimide in der behandlung arzneiresistenter protozoeninjektionen.
SE9601395D0 (sv) New therapeutic treatment 1
ATE111357T1 (de) Synergetische immunostimulierende zusammensetzung und ihre verwendung.
ES2065951T3 (es) Uso de un inhibidor de prolilendopeptidasa para el tratamiento del sida.
ATE64300T1 (de) Wirkstoffe zur anwendung bei der behandlung von tumoren.
ES2046246T3 (es) Composicion terapeutica para combatir el sida.
MX9301863A (es) Morfolin y tiomorfolin 4-ilamidas
SE8403659L (sv) Synergistiska farmaceutiska kompositioner
DE69010523D1 (de) Kit oder Zusammensetzung zur Vorbeugung oder Behandlung von HIV-1 Infektionen.
ES2148268T3 (es) Composicion farmaceutica para prevenir o tratar fracturas de huesos.
DE3378979D1 (en) 1-acyl-3-pyridylmethylguanidines and their use as antihypertensive agents

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 355409

Country of ref document: ES